Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis
Serrated colorectal cancer (CRC) accounts for approximately 25% of cases and includes tumours that are among the most treatment resistant and with worst outcomes. This CRC subtype is associated with activating mutations in the mitogen-activated kinase pathway gene, BRAF, and epigenetic modifications...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
BMJ Publishing Group
2018
|
| _version_ | 1826283548355592192 |
|---|---|
| author | Lannagan, T Lee, Y Wang, T Roper, J Bettington, M Fennell, L Vrbanac, L Jonavicius, L Somashekar, R Gieniec, K Yang, M Ng, J Suzuki, N Ichinose, M Wright, J Kobayashi, H Putoczki, T Hayakawa, Y Leedham, S Abud, H Yilmaz, Ö Marker, J Klebe, S Wirapati, P Mukherjee, S Tejpar, S Leggett, B Whitehall, V Worthley, D Woods, S |
| author_facet | Lannagan, T Lee, Y Wang, T Roper, J Bettington, M Fennell, L Vrbanac, L Jonavicius, L Somashekar, R Gieniec, K Yang, M Ng, J Suzuki, N Ichinose, M Wright, J Kobayashi, H Putoczki, T Hayakawa, Y Leedham, S Abud, H Yilmaz, Ö Marker, J Klebe, S Wirapati, P Mukherjee, S Tejpar, S Leggett, B Whitehall, V Worthley, D Woods, S |
| author_sort | Lannagan, T |
| collection | OXFORD |
| description | Serrated colorectal cancer (CRC) accounts for approximately 25% of cases and includes tumours that are among the most treatment resistant and with worst outcomes. This CRC subtype is associated with activating mutations in the mitogen-activated kinase pathway gene, BRAF, and epigenetic modifications termed the CpG Island Methylator Phenotype, leading to epigenetic silencing of key tumour suppressor genes. It is still not clear which (epi-)genetic changes are most important in neoplastic progression and we begin to address this knowledge gap herein.We use organoid culture combined with CRISPR/Cas9 genome engineering to sequentially introduce genetic alterations associated with serrated CRC and which regulate the stem cell niche, senescence and DNA mismatch repair.Targeted biallelic gene alterations were verified by DNA sequencing. Organoid growth in the absence of niche factors was assessed, as well as analysis of downstream molecular pathway activity. Orthotopic engraftment of complex organoid lines, but not BrafV600E alone, quickly generated adenocarcinoma in vivo with serrated features consistent with human disease. Loss of the essential DNA mismatch repair enzyme, Mlh1, led to microsatellite instability. Sphingolipid metabolism genes are differentially regulated in both our mouse models of serrated CRC and human CRC, with key members of this pathway having prognostic significance in the human setting.We generate rapid, complex models of serrated CRC to determine the contribution of specific genetic alterations to carcinogenesis. Analysis of our models alongside patient data has led to the identification of a potential susceptibility for this tumour type. |
| first_indexed | 2024-03-07T01:00:31Z |
| format | Journal article |
| id | oxford-uuid:898e9b5a-7eef-44a7-bf35-6207a2e4ab6e |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T01:00:31Z |
| publishDate | 2018 |
| publisher | BMJ Publishing Group |
| record_format | dspace |
| spelling | oxford-uuid:898e9b5a-7eef-44a7-bf35-6207a2e4ab6e2022-03-26T22:25:33ZGenetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesisJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:898e9b5a-7eef-44a7-bf35-6207a2e4ab6eEnglishSymplectic Elements at OxfordBMJ Publishing Group2018Lannagan, TLee, YWang, TRoper, JBettington, MFennell, LVrbanac, LJonavicius, LSomashekar, RGieniec, KYang, MNg, JSuzuki, NIchinose, MWright, JKobayashi, HPutoczki, THayakawa, YLeedham, SAbud, HYilmaz, ÖMarker, JKlebe, SWirapati, PMukherjee, STejpar, SLeggett, BWhitehall, VWorthley, DWoods, SSerrated colorectal cancer (CRC) accounts for approximately 25% of cases and includes tumours that are among the most treatment resistant and with worst outcomes. This CRC subtype is associated with activating mutations in the mitogen-activated kinase pathway gene, BRAF, and epigenetic modifications termed the CpG Island Methylator Phenotype, leading to epigenetic silencing of key tumour suppressor genes. It is still not clear which (epi-)genetic changes are most important in neoplastic progression and we begin to address this knowledge gap herein.We use organoid culture combined with CRISPR/Cas9 genome engineering to sequentially introduce genetic alterations associated with serrated CRC and which regulate the stem cell niche, senescence and DNA mismatch repair.Targeted biallelic gene alterations were verified by DNA sequencing. Organoid growth in the absence of niche factors was assessed, as well as analysis of downstream molecular pathway activity. Orthotopic engraftment of complex organoid lines, but not BrafV600E alone, quickly generated adenocarcinoma in vivo with serrated features consistent with human disease. Loss of the essential DNA mismatch repair enzyme, Mlh1, led to microsatellite instability. Sphingolipid metabolism genes are differentially regulated in both our mouse models of serrated CRC and human CRC, with key members of this pathway having prognostic significance in the human setting.We generate rapid, complex models of serrated CRC to determine the contribution of specific genetic alterations to carcinogenesis. Analysis of our models alongside patient data has led to the identification of a potential susceptibility for this tumour type. |
| spellingShingle | Lannagan, T Lee, Y Wang, T Roper, J Bettington, M Fennell, L Vrbanac, L Jonavicius, L Somashekar, R Gieniec, K Yang, M Ng, J Suzuki, N Ichinose, M Wright, J Kobayashi, H Putoczki, T Hayakawa, Y Leedham, S Abud, H Yilmaz, Ö Marker, J Klebe, S Wirapati, P Mukherjee, S Tejpar, S Leggett, B Whitehall, V Worthley, D Woods, S Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis |
| title | Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis |
| title_full | Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis |
| title_fullStr | Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis |
| title_full_unstemmed | Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis |
| title_short | Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis |
| title_sort | genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis |
| work_keys_str_mv | AT lannagant geneticeditingofcolonicorganoidsprovidesamolecularlydistinctandorthotopicpreclinicalmodelofserratedcarcinogenesis AT leey geneticeditingofcolonicorganoidsprovidesamolecularlydistinctandorthotopicpreclinicalmodelofserratedcarcinogenesis AT wangt geneticeditingofcolonicorganoidsprovidesamolecularlydistinctandorthotopicpreclinicalmodelofserratedcarcinogenesis AT roperj geneticeditingofcolonicorganoidsprovidesamolecularlydistinctandorthotopicpreclinicalmodelofserratedcarcinogenesis AT bettingtonm geneticeditingofcolonicorganoidsprovidesamolecularlydistinctandorthotopicpreclinicalmodelofserratedcarcinogenesis AT fennelll geneticeditingofcolonicorganoidsprovidesamolecularlydistinctandorthotopicpreclinicalmodelofserratedcarcinogenesis AT vrbanacl geneticeditingofcolonicorganoidsprovidesamolecularlydistinctandorthotopicpreclinicalmodelofserratedcarcinogenesis AT jonaviciusl geneticeditingofcolonicorganoidsprovidesamolecularlydistinctandorthotopicpreclinicalmodelofserratedcarcinogenesis AT somashekarr geneticeditingofcolonicorganoidsprovidesamolecularlydistinctandorthotopicpreclinicalmodelofserratedcarcinogenesis AT gienieck geneticeditingofcolonicorganoidsprovidesamolecularlydistinctandorthotopicpreclinicalmodelofserratedcarcinogenesis AT yangm geneticeditingofcolonicorganoidsprovidesamolecularlydistinctandorthotopicpreclinicalmodelofserratedcarcinogenesis AT ngj geneticeditingofcolonicorganoidsprovidesamolecularlydistinctandorthotopicpreclinicalmodelofserratedcarcinogenesis AT suzukin geneticeditingofcolonicorganoidsprovidesamolecularlydistinctandorthotopicpreclinicalmodelofserratedcarcinogenesis AT ichinosem geneticeditingofcolonicorganoidsprovidesamolecularlydistinctandorthotopicpreclinicalmodelofserratedcarcinogenesis AT wrightj geneticeditingofcolonicorganoidsprovidesamolecularlydistinctandorthotopicpreclinicalmodelofserratedcarcinogenesis AT kobayashih geneticeditingofcolonicorganoidsprovidesamolecularlydistinctandorthotopicpreclinicalmodelofserratedcarcinogenesis AT putoczkit geneticeditingofcolonicorganoidsprovidesamolecularlydistinctandorthotopicpreclinicalmodelofserratedcarcinogenesis AT hayakaway geneticeditingofcolonicorganoidsprovidesamolecularlydistinctandorthotopicpreclinicalmodelofserratedcarcinogenesis AT leedhams geneticeditingofcolonicorganoidsprovidesamolecularlydistinctandorthotopicpreclinicalmodelofserratedcarcinogenesis AT abudh geneticeditingofcolonicorganoidsprovidesamolecularlydistinctandorthotopicpreclinicalmodelofserratedcarcinogenesis AT yilmazo geneticeditingofcolonicorganoidsprovidesamolecularlydistinctandorthotopicpreclinicalmodelofserratedcarcinogenesis AT markerj geneticeditingofcolonicorganoidsprovidesamolecularlydistinctandorthotopicpreclinicalmodelofserratedcarcinogenesis AT klebes geneticeditingofcolonicorganoidsprovidesamolecularlydistinctandorthotopicpreclinicalmodelofserratedcarcinogenesis AT wirapatip geneticeditingofcolonicorganoidsprovidesamolecularlydistinctandorthotopicpreclinicalmodelofserratedcarcinogenesis AT mukherjees geneticeditingofcolonicorganoidsprovidesamolecularlydistinctandorthotopicpreclinicalmodelofserratedcarcinogenesis AT tejpars geneticeditingofcolonicorganoidsprovidesamolecularlydistinctandorthotopicpreclinicalmodelofserratedcarcinogenesis AT leggettb geneticeditingofcolonicorganoidsprovidesamolecularlydistinctandorthotopicpreclinicalmodelofserratedcarcinogenesis AT whitehallv geneticeditingofcolonicorganoidsprovidesamolecularlydistinctandorthotopicpreclinicalmodelofserratedcarcinogenesis AT worthleyd geneticeditingofcolonicorganoidsprovidesamolecularlydistinctandorthotopicpreclinicalmodelofserratedcarcinogenesis AT woodss geneticeditingofcolonicorganoidsprovidesamolecularlydistinctandorthotopicpreclinicalmodelofserratedcarcinogenesis |